Laurie S. Finger, MSN, MN, CNS, NP, CCNS, CPNP-AC Nurse Practitioner, Endocrinology Children's Hospital of New Orleans New Orleans, LA
Aditya V. Dewoolkar, MD Louisiana State University - Health Sciences Center/Children's Hospital of New Orleans Department of Pediatrics, Division of Endocrinology New Orleans, LA
AMA PRA Category 1 Credit TM
NAPNAP CE: 0.75 contact hour (0.25 of which contains pharmacology content) Medium
The incidence and prevalence of obesity in children and adolescents has increased in recent years, and with it the incidence and prevalence of type 2 diabetes mellitus (T2DM). Compared with adults, T2DM in pediatric patients frequently progresses more rapidly, with high rates of early development of comorbidities and often with a less favorable response to treatment. The American Diabetes Association has developed criteria for screening for and managing T2DM in children and adolescents, and it is crucial that clinicians who treat pediatric patients are aware of these guidelines. This activity will address screening, diagnosis, and management considerations for this challenging condition.
This activity is jointly provided by the National Association of Pediatric Nurse Practitioners, Penn State College of Medicine, and MCM Education.
This activity is designed for pediatricians, pediatric NPs, and other clinicians who manage obesity and T2DM in pediatric patients.
Upon completion of this educational activity, the participant should be able to:
Identify pediatric patients who should be screened for T2DM.
Use the ADA criteria to diagnose T2DM in pediatric patients with obesity.
Develop an evidence-based individualized T2DM management plan for pediatric patients with obesity and T2DM.
Laurie S. Finger, MSN, MN, CNS, NP, CCNS, CPNP-AC, has nothing to disclose.
Aditya V. Dewoolkar, MD, has nothing to disclose.
Penn State faculty and staff involved in the development and review of this activity have nothing to disclose.
Lilian McVey, MD, medical writer, has nothing to disclose.
Kathleen Hines, MCM Education VP, Editorial Affairs, has nothing to disclose.
Terry Ann Glauser, MD, MPH, MCM Education VP, Medical Affairs, has nothing to disclose.
It is the policy of the National Association of Pediatric Nurse Practitioners and Penn State College of Medicine to ensure balance, independence, objectivity and scientific rigor in all of their educational activities including those which are sponsored and cosponsored. All faculty are expected to disclose any significant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services discussed in an educational presentation. The intent of this disclosure is not to prevent a presenter with significant financial interest or other relationship from making the presentation, but rather to provide the audience with information with which they can make their own judgments. It remains for the audience to determine whether the speaker's interests or relationships may influence the presentation with regard to exposition or conclusion. Faculty are also expected to openly disclose any off-label, experimental, or investigational use of drugs or devices in their presentations.
Please consult full prescribing information before using any product mentioned in this activity. If using products in an investigational, off-label manner, it is the responsibility of the prescribing clinician to monitor the medical literature to determine recommended dosages and uses of the drugs. Neither the publisher nor the providers promote the use of any agent outside of approved labeling. Credit Statements
This program is accredited for 0.75 NAPNAP CE contact hours (0.25 of which contains pharmacology content) per the National Association of Pediatric Nurse Practitioners Continuing Education Guidelines.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Penn State College of Medicine and MCM Education. Penn State College of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
Penn State College of Medicine designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s). Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Credit is awarded to participants who score 80% or better on the post-test.
The online activity will take approximately 45 minutes to complete.
For questions regarding CME credit, contact Penn State Continuing Education at (717) 531-6483 or ContinuingEd@hmc.psu.edu. Please reference activity code G6260-18-T. Commercial Support Statements
Supported by an educational grant from Novo Nordisk Inc.
Minimum System Requirements: • Pentium III, 600 MHz or Equivalent Processor • 512 MB of RAM • Windows XP, Vista, or 7 • Mac OS X • 800x600 Monitor Resolution • 16-bit Color • 16 bit Sound Card with Speakers
Please turn off all pop-up blockers to allow access to the educational activity.
Click on the "Start program" icon at the bottom of this page. If you are not already registered as a user of this website, this will bring you to the login/registration page where you will be able to register as a new CMEcorner.com member or check existing registration information. When ready, click on the "Continue to Program" icon at the bottom of the screen.
The next screen will permit you to check for or download the Flash player required to run this program and to begin the program presentation. The activity will take approximately 45 minutes to complete.
After you have finished reviewing the activity, click on the "Post-test" button.
Instructions for completing and submitting the post-test and evaluation are provided on the post-test screen.
©2018, MCM Education. All rights reserved. None of the contents may be reproduced in any form without prior written permission from the publisher. The opinions expressed in this educational activity are those of the faculty and do not necessarily reflect the opinions or recommendations of their affiliated institutions, the publisher, the National Association of Pediatric Nurse Practitioners, Penn State College of Medicine, or Novo Nordisk. Any medications, diagnostic procedures, or treatments discussed by the faculty should not be used by clinicians or other health care professionals without first evaluating their patients’ conditions, considering possible contraindications or risks, reviewing any applicable manufacturer’s product information, and comparing any therapeutic approach with the recommendations of other authorities.